Literature DB >> 7910044

Long-term surveillance studies of previously untreated and treated patients, virally uninfected and infected patients--impact on the immune and other systems.

M C Poon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7910044     DOI： 10.1007/bf01774544

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  19 in total

Review 1.  The manufacturing process of recombinant factor VIII, recombinate.

Authors:  E Gomperts; R Lundblad; R Adamson
Journal:  Transfus Med Rev       Date:  1992-10

2.  In vitro and in vivo inhibition of monocyte phagocytic function by factor VIII concentrates: correlation with concentrate purity.

Authors:  K J Pasi; F G Hill
Journal:  Br J Haematol       Date:  1990-09       Impact factor: 6.998

3.  T lymphocytes from hemophiliacs proliferate after exposure to factor VIII product.

Authors:  D S Matheson; B J Green; M C Poon; T J Bowen; M J Fritzler; D I Hoar
Journal:  Vox Sang       Date:  1986       Impact factor: 2.144

4.  Amyloidosis associated with the nephrotic syndrome and transfusion reactions in a haemophiliac.

Authors:  C R Prentice; M M Izatt; J F Adams; G P McNicol; A S Douglas
Journal:  Br J Haematol       Date:  1971-09       Impact factor: 6.998

5.  Capacity to produce interleukin 2 is impaired in haemophilia in the absence and presence of HIV 1 infection.

Authors:  R Madhok; J A Gracie; J Smith; G D Lowe; C D Forbes
Journal:  Br J Haematol       Date:  1990-09       Impact factor: 6.998

6.  Primary pulmonary hypertension in patients with classic hemophilia.

Authors:  G H Goldsmith; R G Baily; D B Brettler; W R Davidson; J O Ballard; T E Driscol; J M Greenberg; C K Kasper; P H Levine; O D Ratnoff
Journal:  Ann Intern Med       Date:  1988-06       Impact factor: 25.391

7.  Unusually high incidence of tuberculosis among boys with haemophilia during an outbreak of the disease in hospital.

Authors:  A C Beddall; F G Hill; R H George; M D Williams; K Al-Rubei
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

Review 8.  The impact of clotting factor concentrates on the immune system in individuals with hemophilia.

Authors:  E D Gomperts; R de Biasi; R De Vreker
Journal:  Transfus Med Rev       Date:  1992-01

9.  Inhibition of interleukin-2 secretion by factor VIII concentrates: a possible cause of immunosuppression in haemophiliacs.

Authors:  R Thorpe; P Dilger; N J Dawson; T W Barrowcliffe
Journal:  Br J Haematol       Date:  1989-03       Impact factor: 6.998

10.  Particulate material in antihemophilic factor (AHF) concentrates.

Authors:  M E Eyster; M E Nau
Journal:  Transfusion       Date:  1978 Sep-Oct       Impact factor: 3.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.